$3.48
0.041.02%
Last update: 9:38 AM
15 minutes delayed
Comments
Loading...
Fulcrum Therapeutics (FULC) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestFulcrum Therapeutics (NASDAQ:FULC) Stock Quotes, Forecast and News Summary
Fulcrum Therapeutics Stock (NASDAQ: FULC) stock price, news, charts, stock research, profile.
| Open | $3.48 |
| Close | - |
| Volume / Avg. | 54.05K / 1.68M |
| Day Range | $3.48 - $3.61 |
| 52 Wk Range | 2.87 - 13.70 |
| Market Cap | $216.84M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 25 |
| Short Interest | 16.08% |
| Days to Cover | 10.61 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Fulcrum Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in cl...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Fulcrum Therapeutics (FULC) stock?
You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.
Who are Fulcrum Therapeutics (FULC) competitors?
Other companies in Fulcrum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Esperion Therapeutics (NASDAQ:ESPR).
What is the forecast, or price target, for Fulcrum Therapeutics (FULC) stock?
Fulcrum Therapeutics has a consensus price target of $7.50.
What is the current price for Fulcrum Therapeutics (FULC)?
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $3.475 last updated September 19, 2024 at 9:38 AM EDT.
Does Fulcrum Therapeutics (FULC) pay a dividend?
There are no upcoming dividends for Fulcrum Therapeutics.
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Fulcrum Therapeutics (FULC) going to split?
There is no upcoming split for Fulcrum Therapeutics.
What sector and industry does Fulcrum Therapeutics (FULC) operate in?
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.